Monte Rosa Therapeutics (GLUE) Non-Current Assets (2023 - 2025)
Historic Non-Current Assets for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $58.0 million.
- Monte Rosa Therapeutics' Non-Current Assets fell 915.72% to $58.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.4 million, marking a year-over-year decrease of 941.72%. This contributed to the annual value of $61.3 million for FY2024, which is 925.48% down from last year.
- As of Q3 2025, Monte Rosa Therapeutics' Non-Current Assets stood at $58.0 million, which was down 915.72% from $60.1 million recorded in Q2 2025.
- Monte Rosa Therapeutics' Non-Current Assets' 5-year high stood at $70.5 million during Q2 2023, with a 5-year trough of $58.0 million in Q3 2025.
- In the last 3 years, Monte Rosa Therapeutics' Non-Current Assets had a median value of $66.2 million in 2024 and averaged $64.9 million.
- In the last 5 years, Monte Rosa Therapeutics' Non-Current Assets tumbled by 111.29% in 2024 and then plummeted by 1002.95% in 2025.
- Over the past 3 years, Monte Rosa Therapeutics' Non-Current Assets (Quarter) stood at $67.5 million in 2023, then dropped by 9.25% to $61.3 million in 2024, then decreased by 5.33% to $58.0 million in 2025.
- Its last three reported values are $58.0 million in Q3 2025, $60.1 million for Q2 2025, and $60.9 million during Q1 2025.